← Eichor
Condition: Stem Cell Transplant Complications Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Stem Cell Transplant Complications

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Moxibustion in the Treatment of Hemorrhagic Cystitis After Allo-HSCT
NA · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06241274
BMT-CARE: Psychosocial Intervention for Transplant Caregivers
NA · 3 location(s) · Massachusetts General Hospital · NCT06472089
IS-free Treg HaploHCT
Phase 1 · 1 location(s) · Dana-Farber Cancer Institute · NCT04678401
Novel First-line Therapies for Grade II Acute GVHD(Graft-versus-host Disease )
Phase 2 · 1 location(s) · Daihong Liu · NCT07340723
Immunological Reset to Enable Access to Hla-compatible Kidney Transplantation in Highly Sensitized Patients (RESET)
Phase 1/Phase 2 · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT07607197
Post Transplant Cyclophosphamide in Matched Unrelated Donor Stem Cell Transplantation for Hematological Malignancies
Phase 2/Phase 3 · 1 location(s) · Hospital Israelita Albert Einstein · NCT03818334
Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05525507
Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT05706766
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
Phase N/A · 1 location(s) · Henry Ford Health System · NCT04623424
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Pati
Phase N/A · 1 location(s) · Mayo Clinic · NCT06752577
Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT06468618
PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Mult
NA · 6 location(s) · Centre Leon Berard · NCT05947136
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
NA · 2 location(s) · Dana-Farber Cancer Institute · NCT05236062
In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome
NA · 1 location(s) · Chinese University of Hong Kong · NCT05797272
Decitabine Plus mBU/CY for High Risk Acute Leukemia With MRD Pre-HSCT
Phase 2/Phase 3 · 1 location(s) · Peking University People's Hospital · NCT03793517
Adipose Stem Cell Mitochondria Supplementation to Oocytes (ASCENT)
NA · 1 location(s) · Sunkaky Medical Cooperation · NCT07066267
Comparison of Intralipid With SMOF Lipid Following HSCT
NA · 1 location(s) · Shahid Beheshti University · NCT06625372
Moxibustion for the Prevention of Hemorrhagic Cystitis After Allo-HSCT
NA · 4 location(s) · Yi Zhang · NCT06198517
Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
Phase 3 · 33 location(s) · Tobias Feuchtinger · NCT04832607
Early Integration of Palliative and Supportive Care in Cellular Therapy
NA · 1 location(s) · Alberta Health Services, Calgary · NCT05190653
Loratadine for the Prevention of G-CSF-related Bone Pain
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05421416
Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling
Phase 2 · 1 location(s) · University of Calgary · NCT03214354
Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients
NA · 1 location(s) · The General Hospital of Western Theater Command · NCT06599346
Novel Therapies for Severe Acute GVHD (Graft-versus-host Disease)
Phase 2 · 1 location(s) · Daihong Liu · NCT07509749
High Heated Humidity in Stem Cell Transplant
Phase 2 · 1 location(s) · AHS Cancer Control Alberta · NCT05358262
Impact of Iron Overload on the Incidence of Liver Complications in Long-Term Survivors (≥10 Years) of Allogeneic Hematop
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07028112
Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From
Phase 1/Phase 2 · 1 location(s) · Alice Bertaina · NCT05508009
Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia After Haplo-HSCT
Phase 2/Phase 3 · 14 location(s) · Peking University People's Hospital · NCT06202625
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Viru
Phase 2 · 11 location(s) · Pulmotect, Inc. · NCT06665100
Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulm
Phase 1/Phase 2 · 1 location(s) · The Children's Hospital of Zhejiang University School of Med · NCT06788470
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.